XML 64 R32.htm IDEA: XBRL DOCUMENT v2.4.1.9
Summary of Significant Accounting Policies - Summary of Collaborators that Represent More Than 10% of Accounts Receivable (Detail) (Accounts Receivable [Member])
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Servier [Member]    
Concentration Risk [Line Items]    
Significant Accounts Receivable 33.30%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
/ us-gaap_ConcentrationRiskByTypeAxis
= mgnx_ServierMember
6.40%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
/ us-gaap_ConcentrationRiskByTypeAxis
= mgnx_ServierMember
Boehringer [Member]    
Concentration Risk [Line Items]    
Significant Accounts Receivable 21.20%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
/ us-gaap_ConcentrationRiskByTypeAxis
= mgnx_BoehringerIngelheimMember
12.20%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
/ us-gaap_ConcentrationRiskByTypeAxis
= mgnx_BoehringerIngelheimMember
Green Cross [Member]    
Concentration Risk [Line Items]    
Significant Accounts Receivable 17.90%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
/ us-gaap_ConcentrationRiskByTypeAxis
= mgnx_GreenCrossCorporationMember
 
Gilead [Member]    
Concentration Risk [Line Items]    
Significant Accounts Receivable   53.40%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
/ us-gaap_ConcentrationRiskByTypeAxis
= mgnx_GileadSciencesIncMember
Pfizer [Member]    
Concentration Risk [Line Items]    
Significant Accounts Receivable   12.30%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
/ us-gaap_ConcentrationRiskByTypeAxis
= mgnx_PfizerIncMember